Clinical trial
A Multicenter, Prospective, Non-randomized Study on Pathophysiology, Diagnosis, and Biofeedback Therapy in Fecal Incontinence (FI) Using Fecobionics (NORMAL and ABNORMAL-FI)
NCT05412069 is registered in ClinicalTrials.gov with The California Medical Innovations Institute, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Prospective, Non-randomized Study on Pathophysiology, Diagnosis, and Biofeedback Therapy in Fecal Incontinence (FI) Using Fecobionics (NORMAL and ABNORMAL-FI)
- Lead sponsor
- The California Medical Innovations Institute, Inc.
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- February 15, 2023
- Completion date
- March 31, 2027
- Enrollment
- 155 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
fecal incontinence, normal subjects